Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.86
-1.07 (-6.72%)
At close: Mar 6, 2026, 4:00 PM EST
15.15
+0.29 (1.95%)
After-hours: Mar 6, 2026, 6:37 PM EST
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
| 64.64M | 33.43M | 67.54M | 98.16M | - | | | | |
| 93.38% | -50.50% | -31.20% | - | - | | | | |
Minimal Residual Disease (MRD) | 212.33M | 145.53M | 102.74M | 87.14M | - | | | | |
Minimal Residual Disease (MRD) Growth | 45.90% | 41.65% | 17.90% | - | - | | | | |
| - | - | - | - | 154.34M | | | | |
| - | - | - | - | 56.88% | | | | |
| 276.98M | 178.96M | 170.28M | 185.31M | 154.34M | | | | |
| 54.77% | 5.10% | -8.11% | 20.06% | 56.88% | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
| 276.98M | 178.96M | 170.28M | 185.31M | 154.34M | | | | |
| 54.77% | 5.10% | -8.11% | 20.06% | 56.88% | | | | |
| 276.98M | 178.96M | 170.28M | 185.31M | 154.34M | | | | |
| 54.77% | 5.10% | -8.11% | 20.06% | 56.88% | | | | |
Source: S&P Global Market Intelligence.
